Urinary Human Papilloma Virus Test in the General Population in Brittany (PapU-Access)
Evaluation of the Impact of a Screening Strategy Based on a Home Urinary Test in Non-respondent Women on a First Invitation to Papillomavirus Screening, on the Participation Rate Compared to a Uterine Cervix Smear Screening, With Taking Into Account the Socio-economic Level, During the Organized Screening for Cervical Cancer in Brittany
Sponsor: ADECAM INDUSTRIE
Listed as NCT03598946, this NA trial focuses on Neoplasms,Ovarian and remains ongoing. Sponsored by ADECAM INDUSTRIE, it has been updated 15 times since 2021, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Aug 2024 — Sep 2024 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Sep 2022 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2021 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 10 earlier versions
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Sep 2020 — Dec 2020 [monthly]
Not Yet Recruiting NA
-
Mar 2020 — Sep 2020 [monthly]
Not Yet Recruiting NA
-
Dec 2019 — Mar 2020 [monthly]
Not Yet Recruiting NA
-
Jun 2019 — Dec 2019 [monthly]
Not Yet Recruiting NA
-
Mar 2019 — Jun 2019 [monthly]
Not Yet Recruiting NA
-
Oct 2018 — Mar 2019 [monthly]
Not Yet Recruiting NA
-
Aug 2018 — Oct 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ADECAM INDUSTRIE
- ADECARMOR
- ADECI35
- Association for the Screening of Cancers in Finistère
- University Hospital, Brest
For direct contact, visit the study record on ClinicalTrials.gov .